Skip to main content
logo
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.395
-0.045 (-1.84%)
At close: Sep 25, 2026, 4:00 PM EDT
2.380
-0.015 (-0.63%)
After-hours: Sep 25, 2026, 7:30 PM EDT

Virax Biolabs Group Revenue

In the fiscal year ending March 31, 2026, Virax Biolabs Group had annual revenue of $12.42K with 96.22% growth. Virax Biolabs Group had revenue of $10.82K in the half year ending March 31, 2026, a decrease of -86.47%.

Revenue (ttm)
$12.42K
Revenue Growth
+96.22%
P/S Ratio
153.65
Revenue / Employee
$478
Employees
26
Market Cap
1.91M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202612.42K6.09K96.22%
Mar 31, 20256.33K-150.09K-95.95%
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 202099.88K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

VRAX News

More News